Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
Active, not recruiting · NCT05551858 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis | Digestive System Diseases, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, pancreas disorder, pancreatitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT05551858 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Georgetown University | 73 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgetown University | Washington D.C. | United States | 38 |